Image
Brenda Sanchez
Developmental Core Manager
Spring 2025 funding cycle: Applications available until Monday, March 3.
- Call opens: Thursday, January 30, 2025
- Deadline: Monday March 3, 2025 (2:00 pm PST)
- Funding results: Available before end of May 2025
Amount available: $50,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The CFAR Mentored Scientist Award (our primary award program) is a mentoring and training grant targeted toward early stage (either at a senior stage of clinical or postdoctoral training or junior faculty) investigators at UCSF or affiliated partner institutes in the conduct of an HIV research project. These awards are designed to acquire preliminary data and research skills to prepare investigators for a future grant effort. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project.
Designation of Mentor
All Mentored award applications from individuals at the Assistant Professor level or below require an HIV research mentor. Mentors can, but are not required to, have supervisory authority over the applicant. CFAR requires your research mentor’s support to advise and guide the research portion of your application before submitting it to RAP.
Of high interest to CFAR are investigations ranging from basic pathogenesis to clinical outcomes in the research areas of HIV/aging and inflammation, latency, cure, vaccines, co-infections, HIV in women, implementation science, and research related to HIV-infected and HIV-impacted Bay Area populations. Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $50,000 in direct costs for one year.
CFAR requests that applicants review the NIAID HIV Language Guide as they prepare their proposals so that they can follow best practices on language for communicating respectfully about HIV and related topics, including the use of person-first, non-stigmatizing language. Please contact us if you have any questions about this request.
For more detailed information about this RFA, please see the RAP Portal.
To see examples of previously funded projects, see the list below.
Mentored Science Awardees
128 Awards
-
Cognitive Impairment in HIV Over 60 Years of Age
Cognitive Impairment in HIV Over 60 Years of Age
Abstract
Publications:
-
Polymerase Chain Reaction (PCR) to identify pneumocystis DNA in oropharyngeal wash (OPW) specimens in Resource-constrained Settings.
Polymerase Chain Reaction (PCR) to identify pneumocystis DNA in oropharyngeal wash (OPW) specimens in Resource-constrained Settings.
Abstract
-
Acceptability and Feasibility of Serial HIV Antibody Testing to Detect Incident HIV Infection During Pregnancy and Lactation and Partner Testing in Tororo, Uganda
Acceptability and Feasibility of Serial HIV Antibody Testing to Detect Incident HIV Infection During Pregnancy and Lactation and Partner Testing in Tororo, Uganda
Abstract
The current practice of single HIV antibody testing for pregnant women in high prevalence areas fails to identify those at risk of acquiring and, in turn, transmitting HIV throughout pregnancy and lactation. The objective of this study is to assess the acceptability and feasibility of serial HIV antibody testing among HIV-uninfected pregnant and breastfeeding women from the initiation of antenatal care until 24 weeks postpartum in Tororo, Uganda. This is a prospective study of 500 HIV-uninfected pregnant women receiving care at the Tororo District Hospital.
-
Subtype and CCR5/CXCR4 Tropism in HIV-1 Infected Ugandan Children
Subtype and CCR5/CXCR4 Tropism in HIV-1 Infected Ugandan Children
Abstract
Publications:
-
Effect of Gluccocorticoids on Innate and Adaptive Immune Responses During HIV Infection
Effect of Gluccocorticoids on Innate and Adaptive Immune Responses During HIV Infection
Abstract
Abstract HIV infection is characterized by high plasma viremia, a progressive loss of CD4+ T cells, and most importantly chronic immune activation, all of which likely contribute to immune dysfunction and disease progression. Although the mechanism(s) resulting in chronic immune activation and impaired immune function are not completely understood, it is likely there is a delicate balance between anti-HIV effector functions and aberrant immune activation.
-
Early Discontinuation of enfuvirtide During Treatment Failure Prevents Establishment of enfuvirtide-resistant Virus in Reservoir.
Early Discontinuation of enfuvirtide During Treatment Failure Prevents Establishment of enfuvirtide-resistant Virus in Reservoir.
Abstract
-
Analysis of Nucleoside Reverse Transcriptase Inhibitor Levels in Intracellular Compartments, Plasma and Hair in HIV-positive Women on HAART
Analysis of Nucleoside Reverse Transcriptase Inhibitor Levels in Intracellular Compartments, Plasma and Hair in HIV-positive Women on HAART
Abstract
Publications:
-
Prevalence, Incidence and Correlates of Kaposi's Sarcoma-Associated Herpesvirus Infection in HIV-Infected and HIV-Uninfected Ugandan Children
Prevalence, Incidence and Correlates of Kaposi's Sarcoma-Associated Herpesvirus Infection in HIV-Infected and HIV-Uninfected Ugandan Children
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) is the viral etiologic agent of Kaposi's sarcoma (KS). In sub-Saharan Africa, the catastrophic intersection between underlying endemic infection with KSHV and the HIV epidemic has resulted in KS becoming the most common malignancy among adults in many countries and a growing cause of cancer in children.
-
Use of Magnetic Resonance Spectroscopy in the Evaluation of Hepatic Lipid Content and Mitochondrial Energy Metabolism in Patients with HIV and HCV Infection
Use of Magnetic Resonance Spectroscopy in the Evaluation of Hepatic Lipid Content and Mitochondrial Energy Metabolism in Patients with HIV and HCV Infection
Abstract
Publications:
-
The Impact of Household Ventilation on Transmission of Tuberculosis Among Household Contacts of Active Tuberculosis Patients in Kampala, Uganda
The Impact of Household Ventilation on Transmission of Tuberculosis Among Household Contacts of Active Tuberculosis Patients in Kampala, Uganda
Abstract
Tuberculosis (TB) is the leading cause of death in persons living with HIV (PLHIV) in sub-Saharan Africa and TB incidence is increasing worldwide despite infection control efforts as the two epidemics fuel one another. In Kampala, Uganda, roughly one in four HIV-infected household contacts of TB patients have active TB. Reducing household TB transmission is likely to significantly reduce TB incidence in PLHIV. We hypothesize that household TB transmission is related to poor ventilation.